XML 58 R41.htm IDEA: XBRL DOCUMENT v3.25.4
INCOME TAXES (Tables)
 12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Tax The components of the income (loss) before taxes were as follows:
Year ended
December 31,
202520242023
Israel$22,289 $7,200 $(65,764)
Foreign10,476 6,737 (10,777)
Total income (loss) before taxe
$32,765 $13,937 $(76,541)
Schedule of Components of Income Tax Expense (Benefit) Taxes on income (tax benefit) are comprised as follows:    
Year ended
December 31,
202520242023
Current :
Israel$4,176 $1,001 $1,363 
Foreign13,175 26,014 19,632 
Total current income tax expense17,351 27,015 20,995 
Deferred:
Israel(17,487)— — 
Foreign(9,383)(9,318)(15,496)
Total deferred income tax benefit
(26,870)(9,318)(15,496)
Total tax on income (tax benefit)$(9,519)$17,697 $5,499 
Schedule of Effective Income Tax Rate Reconciliation
Upon adoption of ASU 2023-09, Improvements to Income Tax Disclosures, as described in Note 2, Summary of Significant Accounting Policies, the reconciliation of taxes at the federal statutory rate to our provision for (benefit from) income taxes are as follows :
Year Ended December 31, 2025
AmountPercent
Israeli Statutory Corporate Tax Rate
$7,536 23.0 %
Preferred Tax Rate Differential$(2,158)(6.6)%
Foreign Tax Effects
United States
Statutory Tax Rate difference between Israel and United States
$466 1.4 %
Share Based Compensation
$2,957 9.0 %
Research and Development Tax Credits
$(926)(2.8)%
Nondeductible Compensation
$2,667 8.1 %
Foreign-Derived Intangible Income
$(1,131)(3.5)%
State and Local Taxes
$(465)(1.4)%
Changes in Valuation Allowances
$456 1.4 %
Others$112 0.3 %
United Kingdom
Welfare Expenses
$657 2.1 %
Nondeductible Intangible Amortization
$(989)(3.0)%
Research and Development Tax Credits
$(352)(1.1)%
Changes in Valuation Allowances
$(1,344)(4.1)%
Exchange Rate Movement
$(482)(1.5)%
Others$59 0.1 %
Brazil
Withholding Tax
$1,028 3.1 %
Changes in Valuation Allowances
$(874)(2.7)%
Other
$(872)(2.7)%
Germany
Nontaxable Unrealized Gains
$(402)(1.2)%
Others
$189 0.6 %
Other Foreign Jurisdictions
$(703)(2.1)%
Changes in Valuation Allowances$(19,599)(59.8)%
Nontaxable or Nondeductible Items
Share Based Compensation
$1,860 5.7 %
Others
$552 1.7 %
Changes in Unrecognized Tax Benefits$1,732 5.3 %
Other Adjustments$509 1.6 %
Effective Tax Rate$(9,519)29.0 %
Year ended
December 31,
20242023
Income (loss) before taxes on income, as reported in the consolidated statements of income (loss)$13,937 $(76,541)
Statutory tax rate in Israel23 %23 %
Preferred Technology Enterprise benefits(6)%(9)%
Permanent difference - nondeductible expenses50 %(9)%
Change in valuation allowance10 %(11)%
Income taxes at a rate other than the Israel statutory tax rate26 %(2)%
Prior years taxes5 %2 %
Uncertain tax position15 %(6)%
Other4 %5 %
Effective tax rate127 %(7)%
Schedule of Deferred Tax Assets and Liabilities
Deferred taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. As of December 31, 2025, and 2024 , the deferred tax assets and liabilities presented in the balance sheet are comprised as follow:
Year ended
December 31,
20252024
Deferred tax assets$20,624 $— 
Deferred tax liabilities$(628)$(5,497)
Deferred tax assets, net
$19,996 $(5,497)

                            
As of December 31, 2025, and 2024 the Company’s deferred taxes were in respect of the following:        
Year ended
December 31,
20252024
Carry forward tax losses$360 $3,196 
Research and development1,785 3,410 
Operating lease liability17,119 13,064 
Reserves and Allowances5,361 5,938 
Share-based compensation expenses11,891 11,787 
Tax credit carry forward10,839 10,094 
Issuance and Transaction expenses— 335 
Intangibles assets, net633 1,358 
Interest expense carried forward497 2,423 
Other286 534 
Deferred tax assets before valuation allowance48,771 52,139 
Valuation allowance(6,112)(26,179)
Deferred tax asset42,659 25,960 
Intangibles assets, net(3,958)(16,772)
Property and equipment, net(3,063)(1,617)
Capitalized research and development(876)(1,374)
Operating lease right-of-use assets(14,757)(11,682)
Other(9)(12)
Deferred tax liabilities(22,663)(31,457)
Deferred tax liabilities, net$19,996 $(5,497)
Schedule of Income Taxes Paid, Net of Refunds
Upon adoption of ASU 2023-09, Improvements to Income Tax Disclosures, as described in Note 2, Summary of Significant Accounting Policies, cash paid for income taxes, net of refunds, during the year ended December 31, 2025 was as follows (in thousands):
Year ended
December 31,
2025
Israel$140 
Foreign
United States
Federal
$10,800 
States
$1,615 
United Kingdom$11,181 
Brazil$2,001 
Other foreign jurisdictions
$3,958 
Total$29,695 
Schedule of Unrecognized Tax Benefits Roll Forward
A reconciliation of the beginning and ending balance of total unrecognized tax positions is as follows:                        
Year ended
December 31,
20252024
Unrecognized tax position, beginning of year$10,291 $8,216 
Increases related to current years’ tax positions3,394 1,712 
Increase related to prior years' tax positions
650 544 
Decreases due to lapses of statutes of limitations(2,312)(181)
Decreases due to settlements with tax authorities
(430)— 
Unrecognized tax position, end of year$11,593 $10,291 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The potential number of Ordinary shares that were excluded from the computation of diluted net income (loss) per share attributable to Ordinary shareholders for the periods presented because including them would have been anti-dilutive is as follows:
Year ended
December 31,
202520242023
RSUs9,159,556 20,209,991 25,554,224 
Outstanding share options7,332,399 11,812,628 27,397,556 
Warrants12,349,990 12,349,990 12,349,990 
Issuable Ordinary shares related to business combination under holdback arrangement— 484,500 1,647,292 
Total28,841,945 44,857,109 66,949,062